UPMC to Help Deliver Better Care in India and Kazakhstan While Bringing New Revenue and Ideas to Western Pa.
PITTSBURGH, May 10, 2013 – UPMC today announced the signing of two consulting agreements that promise to improve the delivery of health care in Kazakhstan and India, while generating revenue and fostering an exchange of ideas that will advance UPMC’s care and scientific research in western Pennsylvania.
- Help implement a UPMC-developed blueprint for creating a national oncology treatment and research center in Kazakhstan, funded by the government and designed to dramatically improve cancer survival rates in that country.
- Collaborate with Citizens Hospital in India to create a world-class clinical pathology laboratory on the hospital’s campus in Hyderabad.
“UPMC’s reputation for clinical excellence and innovation continues to attract a growing number of partners who want advisors with deep health care expertise and experience in overcoming the same challenges they face. Our Advisory Services unit is structured to give us the ability and flexibility to react quickly to such needs, while laying the groundwork for potentially long-term relationships,” said Charles Bogosta
, executive vice president of UPMC and president of ICSD.
Improving Cancer Care in Kazakhstan
After working on plans since last July for a national oncology treatment and research center in Kazakhstan, UPMC has been chosen by Nazarbayev University to help implement this ambitious blueprint for transforming the delivery of cancer care. More than 30,000 new cases of cancer are detected in Kazakhstan annually—with over half of all cancer patients being diagnosed at later stages.
UPMC developed the feasibility plan for the national cancer center by assessing the types of oncology services required and suggesting strategies that will improve care, promote technology adoption and research, and expand education opportunities. Under this new agreement, UPMC will help to implement that plan over the next year and provide access to clinical training in Pittsburgh.
Raising Pathology Laboratory Standards in India
As part of its vision of raising health care standards in India to the highest levels, Citizens Hospital has signed an agreement with UPMC to assist in the creation of a clinical pathology laboratory on the 10.5-acre campus in Hyderabad, a metropolitan area of more than 7 million people.
Operating under the name AmPath, the lab initially is serving the Citizens Healthcare Campus, which opened its first phase in August, including a dedicated oncology facility. When fully operational in 2015, Citizens will include more than 650 patient rooms and offer the entire spectrum of health care services.
UPMC will help the lab at Citizens expand its capabilities, including the addition of increasingly complex molecular diagnostic testing modalities. The facility is expected to become a reference lab serving patients throughout all of India, as well as the Middle East and Southeast Asia. Citizens Hospital is contributing the infrastructure and operational management for the lab, and UPMC is providing clinical expertise and continuous consultation.
“Advisory Services provides our clinical partners with access to a wide-ranging portfolio of UPMC’s expertise, based on its position as one of the nation’s most acclaimed and technologically sophisticated health care networks,” said David Russell, who is leading the new group.
Advisory Services is focusing primarily on four key areas—oncology, information technology, pediatrics and health security—but has the flexibility to meet client needs across a broad range of clinical specialties. It helps partners expand their clinical services and improve care processes through the implementation of clinical protocols and new care models, training of clinical and administrative staff, technology assessments and implementation, facility planning and construction, development of research programs, and emergency preparedness planning.
UPMC’s international footprint already includes operations or services in Italy, Ireland, China, Singapore and Japan. Through its international growth and commercialization efforts with industry partners, UPMC is diversifying its revenue base, fueling economic development in its communities, and strengthening its ability to recruit and retain the best and brightest clinicians who are working together to improve health care outcomes globally.